Emery Dreifuss Muscular Dystrophy: Difference between revisions

No edit summary
No edit summary
Line 22: Line 22:
add text here <br>  
add text here <br>  


== Associated Co-morbidities  ==
== Associated Co-morbidities<br> ==


add text here <br>  
Individuals with EDMD present with a wide variety of cardiac abnormalities including atrial standstill, atrial fibrillation, congestive heart failure, and cardioembolic stroke. The population is at high risk for devloping severe bradyarrhythmias which carries a risk of sudden death, and supraventricular tachyarrhythmias which are associated with a high risk for thromboembolic stroke. &nbsp;It is important to note that cardiac and muscular involvement have not been shown to be closesly related, with cases of severe cardiomyopathy occuring in patients with only mild muscular symptoms. It is possible for stroke to be the first clinical manifestation of EDMD.<ref name="AHA">Boriani G, Gallina M, Merlini L, et al. Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy: A Long-Term Longitudinal Study . Stroke . 2003;34 (4 ):901–908. Available at: http://stroke.ahajournals.org/content/34/4/901.abstract.</ref>
 
<br>


== Medications  ==
== Medications  ==

Revision as of 01:03, 4 March 2014

Welcome to PT 635 Pathophysiology of Complex Patient Problems This is a wiki created by and for the students in the School of Physical Therapy at Bellarmine University in Louisville KY. Please do not edit unless you are involved in this project, but please come back in the near future to check out new information!!

Definition/Description[edit | edit source]

add text here

Prevalence[edit | edit source]

There are approximately 250,000 individuals in the United States affected by some type of muscular dystrophy.[1]

The incidence of X-linked Emery Dreifuss Muscular Dystrophy is estimated to affect 1 in 100,000 people in the general population[2][3], and it is believed to be the third most common type of muscular dystrophy.[1] X-linked EDMD is fully expressed in males only; however, 10-20% of female carriers for X-linked EDMD will develop heart conduction defects and/or muscle weakness.[1]

The frequency of autosomal dominant EDMD is unknown. The autosomal recessive type of the disorder is very rare, with only a few reported cases worldwide.[3] The autosomal types of EDMD affect males and females equally. [1]


Characteristics/Clinical Presentation[edit | edit source]

add text here

Associated Co-morbidities
[edit | edit source]

Individuals with EDMD present with a wide variety of cardiac abnormalities including atrial standstill, atrial fibrillation, congestive heart failure, and cardioembolic stroke. The population is at high risk for devloping severe bradyarrhythmias which carries a risk of sudden death, and supraventricular tachyarrhythmias which are associated with a high risk for thromboembolic stroke.  It is important to note that cardiac and muscular involvement have not been shown to be closesly related, with cases of severe cardiomyopathy occuring in patients with only mild muscular symptoms. It is possible for stroke to be the first clinical manifestation of EDMD.[4]


Medications[edit | edit source]

add text here

Diagnostic Tests/Lab Tests/Lab Values[edit | edit source]

add text here

Etiology/Causes[edit | edit source]

add text here

Systemic Involvement[edit | edit source]

add text here

Medical Management (current best evidence)[edit | edit source]

add text here

Physical Therapy Management (current best evidence)[edit | edit source]

add text here

Alternative/Holistic Management (current best evidence)[edit | edit source]

add text here

Differential Diagnosis[edit | edit source]

add text here

Case Reports/ Case Studies[edit | edit source]

add links to case studies here (case studies should be added on new pages using the case study template)

Resources
[edit | edit source]

add appropriate resources here

Recent Related Research (from Pubmed)[edit | edit source]

see tutorial on Adding PubMed Feed

Extension:RSS -- Error: Not a valid URL: addfeedhere|charset=UTF-8|short|max=10

References[edit | edit source]

see adding references tutorial.

  1. 1.0 1.1 1.2 1.3 Lammerding, J. Emery Dreifuss Muscular Dystrophy. Available at: http://www.rarediseases.org/rare-disease-information/rare-diseases/byID/590/viewFullReport. Accessed March 3, 2014. (accessed 3 March 2014).
  2. Helbling-Leclerc A, Bonne G, Schwartz K. Emery Dreifuss Muscular Dystrophy. http://www.nature.com/ejhg/journal/v10/n3/full/5200744a.html (accessed 3 March 2014).
  3. 3.0 3.1 Emery Dreifuss Muscular Dystrophy. http://ghr.nlm.nih.gov/condition/emery-dreifuss-muscular-dystrophy (accessed 3 March 2014).
  4. Boriani G, Gallina M, Merlini L, et al. Clinical Relevance of Atrial Fibrillation/Flutter, Stroke, Pacemaker Implant, and Heart Failure in Emery-Dreifuss Muscular Dystrophy: A Long-Term Longitudinal Study . Stroke . 2003;34 (4 ):901–908. Available at: http://stroke.ahajournals.org/content/34/4/901.abstract.